Navigation Links
JHP Pharmaceuticals Enters Agreement to Produce Unique Late Stage Ophthalmic Product
Date:9/16/2013

PARSIPPANY, N.J., Sept. 16, 2013 /PRNewswire/ -- JHP Pharmaceuticals, a leading provider of global contract manufacturing services for sterile products, is pleased to announce that it has entered into a manufacturing agreement with an undisclosed pharmaceutical company which has developed proprietary products that provide sustained and localized drug concentration. The agreement is for technical transfer, registration batch manufacture and commercial supply of a unique late stage ophthalmic product.

JHP's manufacturing expertise and cGMP compliance history were critical factors in the selection process. Stuart Hinchen, President and CEO stated, "This important product has critical manufacturing requirements. We have successfully manufactured and filled a number of different products over the past few years, all with unique parameters. Our experience in this area provides our customers with a sound resource as the product moves through launch and commercialization. Our record of cGMP compliance driven by experienced quality and regulatory teams continues to be one of the key reasons customers chose JHP." 

Hinchen noted, "JHP is now expanding its manufacturing capabilities by introducing a new ophthalmic filling line that will further enhance production effectiveness. This innovative equipment will offer a disposable filling circuit, reduced line losses and broader product handling capabilities all in a restricted access configuration. At the moment, the new filling line is under construction and is expected to be fully operational during the second half of 2014."

JHP Pharmaceuticals, located in Rochester, Michigan, has over 27 years' experience in contract manufacturing. It has developed many partnerships in its history manufacturing clinical and commercial products. JHP has successfully supported launches of several products in US and international markets. Currently it manufactures products for sale in 86 countries. 

About JHP Pharmaceuticals, LLCJHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile products including biologics, small molecule, controlled substances, vaccines, ophthalmics, otics and antibiotics for large and small pharmaceutical and biotech organizations.

JHP's sterile manufacturing facility, located in Rochester Michigan sits on over 85 acres of land and includes a 171,000 sq. ft. production building and warehouse.  The production facility utilizes three high-speed filling lines, a clinical filling line, an ophthalmic filling line and four lyophilizers.  The site includes a new, innovatively-designed facility for chemistry, sterility testing and analytical methods development. 

JHP has the capability to manufacture small-scale clinical through large-scale commercial products.  JHP employs more than 400 staff in the USA in its manufacturing, product development, regulatory, sales and marketing and corporate areas.  For more information, please visit www.jhppharma.com.Contact:Dan Leone 973.658.3559Bill Conway  877.906.7556 jhpcontractservices@jhppharma.com MK513 


'/>"/>
SOURCE JHP Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Actinium Pharmaceuticals Appoints Kaushik J. Dave, Ph.D., MBA As President, Chief Executive Officer And Director
2. Frost & Sullivan Lauds Adcock Ingrams Capability to Innovatively Cater to the Dynamic Needs of Emerging Pharmaceuticals Markets
3. Dr. David Hangauer, Chief Scientific Officer and Co-Founder, commits his career to Kinex Pharmaceuticals
4. Access Pharmaceuticals Awarded Second European Patent for MuGard
5. Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
6. Caldera Pharmaceuticals Announces Closing of Financing
7. HedgePath Pharmaceuticals Enters into Key Collaboration with Mayne Pharma
8. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
9. Roche and Inovio Pharmaceuticals partner on Inovios prostate cancer and hepatitis B immunotherapy products
10. UHC to Launch New Specialty Pharmacy Program for Better Continuity of Patient Care, Improved Access to Specialty Pharmaceuticals
11. DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ... offering of 11,027,558 shares of its common stock by ... and Goldman Sachs.  The shares are being sold to ... share. The selling stockholders will receive all of the ... of its directors, officers or other stockholders is selling ...
(Date:2/5/2016)... 2016  Henry Schein, Inc. (NASDAQ: HSIC ), the ... to office-based dental, animal health and medical practitioners, announced ... acquire a majority ownership interest in Dental Cremer S.A., ... Brazil . --> ... is the dental distribution business of Cremer S.A. With ...
(Date:2/5/2016)... France , Germany ... and Israel ). It includes a 10-year epidemiology forecast ... segmented by age and sex in these markets. GD epidemiology report is ... in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends ... Germany , Italy , Spain ...
Breaking Medicine Technology:
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood , ... medical and surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, ... non-surgical alternative for reduction of fat below the chin (aka the “double chin”). ...
(Date:2/6/2016)... San Rafael, CA (PRWEB) , ... February 06, 2016 , ... ... 2016 Youth Ultimate Coaching Conference (YUCC) . This event brings together top non-profit leaders, ... is “Gender Equity and Girls Ultimate”. Valerio Iani, Bay Area Disc Program Director of ...
(Date:2/6/2016)... St. Petersburg, FL (PRWEB) , ... February 06, 2016 , ... ... AsSeenOnTV.pro are pleased to announce the launch of a new DRTV campaign with Belly ... rug. If having tried everything from sprays to puppy pads and find nothing works, ...
(Date:2/5/2016)... ... ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon on ... This year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped to ... , This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap on ...
(Date:2/5/2016)... ... February 05, 2016 , ... VeloReality President ... next generation LYNX VR Indoor Trainer with multi-rider capability to an enthusiastic audience ... not only reduce the weight of the unit, they also enhance the rider's ...
Breaking Medicine News(10 mins):